Question for Experts: What is the obstacle to cloning antibodies at sufficient scale to give everyone a shot of extra COVID-19 immunity? Is it an equipment shortage, red tape, funding issue, or what? Antibodies exist and cloning is current technology. What's the holdup?
-
-
There are many monoclonal antibody therapeutics available. I use 2 Repatha and Praluent, which are monoclonal antibodies to PCSK9, a molecule involved in cholesterol transport/metabolism. They are very safe, and well tolerated. One concern would be can enough be given to matter
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Not easy to develop, need to choose a specific antibody to clone (each recovered patient would make their own similar version of anti covid antibodies), scaling production doable but takes time. Safety generally good (usually injection site irritation most common reaction)
-
"own similar version" of antibody. So given the diversity of the human genome, how many different antibodies are possible? And given the diversity of the SARS-COV-2 out there, what are the chances all antibodies are equally effective across all strains?
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.